TÜBİTAK MAM and ALTAYLAR MEDICAL Cooperation Agreement Signed

Share this News

In the world where competition is increasing day by day in direct proportion to the size of the medical market, the first cooperation agreement of TÜBİTAK MAM was signed between TÜBİTAK Marmara Research Center and Altaylar Medical Company within the scope of TEYDEB 1505 University-Industry Cooperation Support Program. Within the scope of this project, the new generation product to be developed by TÜBİTAK MAM will be produced by Altaylar Medical Company and a license fee will be paid to TÜBİTAK MAM through the commercialization process and the sale of the products. With this project, which envisages the domestic production of new generation composite and biodegradable materials to be used in surgical operations in our country, it is aimed to make our country a producer in the relevant field and to gain an important prestige with the products that are thought to be obtained in a unique structure for the first time in the world.

For questions and suggestionsContact Us

Most Recent